More Articles

Access and Evidence

Out With The OId, In With The New

Danielle Barron, (Jan 12, 2018)

Pharma must seek alternative pricing models if it is to become a greater dynamic force
Access and Evidence

It's Not You, It's Me

Danielle Barron, (Jan 8, 2018)

Despite its ups and downs, the relationship between pharma and payers is stronger than ever
Access and Evidence

The 5 conditions you need to deploy blockchain technology

Andy Robertson, (Jan 6, 2018)

Richie Etwaru, Chief Digital Officer at IQVIA explaining the 5 conditions you need in order to deploy blockchain.
Patients and Medical

Medical Under The Microscope

Danielle Barron, (Jan 5, 2018)

Nestlé Health Science's Chief Medical Officer presents the pluses of applying a more scientific approach to medical
Patients and Medical

Carers: The Forgotten Heroes of Healthcare

Hugh Gosling, (Dec 19, 2017)

A new campaign to raise awareness of the needs of care-givers is paving the way for pharma to not just go beyond the pill but also beyond the patient

The Death Of The Brand

Adam Chapman, (Dec 19, 2017)

As pharma waves goodbye to brand-led strategies, how is this changing relationships with HCPs?

Surfing The Innovation Wave

Hugh Gosling, (Dec 18, 2017)

With incredible innovation coming down the pike, pharma must do more to help health systems cope, says EFPIA’s Nathalie Moll

Meet AI, The Doctor’s New Best Friend

Adam Chapman, (Dec 14, 2017)

AI insights will transform HCPs' practice in more ways than one, says Teva SVP Markus Leyck Dieken

How Blockchain Will Help Pharma

Andy Robertson, (Dec 10, 2017)

Watch Richie Etwaru, Chief Digital Officer of IQVIA, below explain how blockchain, the technology behind bitcoin, can create a long-term trust improvement with pharmaceutical companies and their customers – but that we must understand the technology before it can be applied to clinical trials, contracting, approvals and more.

Four Reasons Why Pharma Struggles To Engage HCPs Online (And How To Change That)

Danielle Barron, (Dec 8, 2017)

Pharma is failing to reach one of its critical customers in the online space, says Sanofi VP, Bozidar Jovicevic